A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

Pal, Sumanta K ; Tangen, Catherine ; Thompson, Ian M ; Balzer-Haas, Naomi ; George, Daniel J ; Heng, Daniel Y C ; Shuch, Brian ; Stein, Mark ; Tretiakova, Maria ; Humphrey, Peter ; Adeniran, Adebowale ; Narayan, Vivek ; Bjarnason, Georg A ; Vaishampayan, Ulka ; Alva, Ajjai ; Zhang, Tian ; Cole, Scott ; Plets, Melissa ; Wright, John ; Lara, Primo N

The Lancet (British edition), 2021-02, Vol.397 (10275), p.695-703 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível